VSEE HEALTH INC WTS 29
VSEEW
22 hedge funds and large institutions have $421K invested in VSEE HEALTH INC WTS 29 in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.
8.5% more ownership
Funds ownership: 23.95% → 32.46% (+8.5%)
5% more funds holding
Funds holding: 21 → 22 (+1)
12% less capital invested
Capital invested by funds: $477K → $421K (-$56.6K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$9.47K |
| 2 |
SG
StoneX Group
New York
|
+$135 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$299 |
| 2 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
-$25 |
| 3 |
CS
Clear Street
New York
|
-$4 |
VSEEW Hedge Fund Activity: Q2 2025 in Review
22 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in VSEE HEALTH INC WTS 29 (VSEEW) for Q2 2025, worth a combined $421K — down 12% from $477K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new VSEEW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $9.47K. The largest seller was AQR Arbitrage, cutting an estimated $299.
- 22 institutional investors held VSEE HEALTH INC WTS 29 (VSEEW) as of Q2 2025, up from 21 in Q1 2025.
- Funds reported $421K of VSEE HEALTH INC WTS 29 stock for Q2 2025, down 12% quarter-over-quarter.
- 1 fund opened new VSEE HEALTH INC WTS 29 positions in Q2 2025 and 0 closed out, a net change of +1 holder.
- The largest VSEE HEALTH INC WTS 29 buyer in Q2 2025 was Toronto Dominion Bank, an estimated $9.47K added.
- The largest VSEE HEALTH INC WTS 29 seller in Q2 2025 was AQR Arbitrage, an estimated $299 sold.
Based on aggregated 13F filings for Q2 2025.